Yesterday was the tenth anniversary of my father's death. He died of an infection, but the underlying cause was blood cancer. Multiple myloma.
Today, the pharmaceutical company Celgene is pursuing a new drug to be used against multiple myloma that has the oncology community excited. It's far too late for Dad, but it's good to see progress possibly being made.
No comments:
Post a Comment